BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9663842)

  • 1. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Hedenström H; Alm C; Kraft M; Grahnén A
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
    Löser C; Burlage M; Fölsch UR
    Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
    Arnestad JS; Kleveland PM; Waldum HL
    Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
    Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
    Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
    Lin CJ; Huang CL; Hsu HW; Chen TL
    Acta Anaesthesiol Sin; 1996 Dec; 34(4):179-84. PubMed ID: 9084544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
    Peghini PL; Katz PO; Castell DO
    Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA; Mills JG
    Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.
    Smout AJ; Jonkman JH; Peeters PA; De Bruin H
    Aliment Pharmacol Ther; 1995 Feb; 9(1):51-6. PubMed ID: 7766744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
    Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
    J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
    Watson RG; Johnston BT; Tham TC; Kersey K
    Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
    Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of effervescent ranitidine on gastric pH: comparison with almagate and placebo in fasting and postprandial conditions.
    Rey E; Poves-Francés C; Sánchez G; Fueyo A; Badiola C; Díaz-Rubio M
    Aliment Pharmacol Ther; 2004 Sep; 20(6):683-8. PubMed ID: 15352917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.